Publicacións en colaboración con investigadores/as de Hospital de la Santa Creu i Sant Pau (17)

2021

  1. Spanish Heart Transplant Registry. 32nd Official Report of the Heart Failure Association of the Spanish Society of Cardiology

    Revista Espanola de Cardiologia, Vol. 74, Núm. 11, pp. 962-970

2020

  1. Spanish Heart Transplant Registry. 31th Official Report of the Heart Failure Association of the Spanish Society of Cardiology

    Revista Espanola de Cardiologia, Vol. 73, Núm. 11, pp. 919-926

2017

  1. Evaluation of humoral immunity profiles to identify heart recipients at risk for development of severe infections: A multicenter prospective study

    Journal of Heart and Lung Transplantation, Vol. 36, Núm. 5, pp. 529-539

2015

  1. Donor/recipient sex mismatch and survival after heart transplantation: Only an issue in male recipients? An analysis of the Spanish Heart Transplantation Registry

    Transplant International, Vol. 28, Núm. 3, pp. 305-313

  2. First report of the Spanish Post-Heart-Transplant Tumor Registry

    Revista Espanola de Cardiologia Suplementos, Vol. 15, Núm. S2, pp. 50-57

  3. Impact of clinical profile of donor, recipient, and ischemia time on survival of heart transplant patients. Subanalysis of the Spanish Heart Transplantation Registry

    Cirugia Cardiovascular, Vol. 22, Núm. 6, pp. 279-286

  4. Registro Español de Trasplante Cardiaco (Adultos). XXV Informe Oficial de la Sección de Insuficiencia Cardiaca y Trasplante Cardiaco de la Sociedad Española de Cardiología (1984-2013)

    Revista Espanola de Cardiologia Suplementos, Vol. 15, Núm. S2, pp. 31-42

2014

  1. The falling incidence of hematologic cancer after heart transplantation

    Clinical Transplantation, Vol. 28, Núm. 10, pp. 1142-1147

  2. Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: Calcineurin-inhibitors conversion or minimization?

    International Journal of Cardiology, Vol. 171, Núm. 1, pp. 15-23

2013

  1. Rejection after conversion to a proliferation signal inhibitor in chronic heart transplantation

    Clinical Transplantation, Vol. 27, Núm. 6

2012

  1. Steroid Withdrawal during 5 years following heart transplantation, and the relationship between steroid dosage at 1-year follow-up and complications during the next 2 years: Results from the restco study

    Transplantation Proceedings

  2. Transplantation for complex congenital heart disease in adults: A subanalysis of the Spanish Heart Transplant Registry

    Clinical Transplantation, Vol. 26, Núm. 5, pp. 755-763

  3. Withdrawal of proliferation signal inhibitors due to adverse events in the maintenance phase of heart transplantation

    Journal of Heart and Lung Transplantation, Vol. 31, Núm. 3, pp. 288-295

2011

  1. Lung cancer after heart transplantation: Results from a large multicenter registry

    American Journal of Transplantation, Vol. 11, Núm. 5, pp. 1035-1040

2010

  1. Prevalence and severity of renal dysfunction among 1062 heart transplant patients according to criteria based on serum creatinine and estimated glomerular filtration rate: Results from the CAPRI study

    Clinical Transplantation, Vol. 24, Núm. 4

  2. Risk factors associated with moderate-to-severe renal dysfunction among heart transplant patients: Results from the CAPRI study

    Clinical Transplantation, Vol. 24, Núm. 5, pp. 194-200

  3. Temporal trends in the use of proliferation signal inhibitors in maintenance heart transplantation: A Spanish multicenter study

    Transplantation Proceedings, Vol. 42, Núm. 8, pp. 2997-3000